112 related articles for article (PubMed ID: 24649876)
1. Immunosuppressive agents and interstitial lung disease: what are the risks?
Meyer KC
Expert Rev Respir Med; 2014 Jun; 8(3):263-6. PubMed ID: 24649876
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy for autoimmune lung diseases.
Meyer KC; Bierach J
Immunol Allergy Clin North Am; 2012 Nov; 32(4):633-69. PubMed ID: 23102070
[TBL] [Abstract][Full Text] [Related]
3. Therapies for interstitial lung disease: past, present and future.
Kim R; Meyer KC
Ther Adv Respir Dis; 2008 Oct; 2(5):319-38. PubMed ID: 19124380
[TBL] [Abstract][Full Text] [Related]
4. Current status of idiopathic nonspecific interstitial pneumonia.
Poletti V; Romagnoli M; Piciucchi S; Chilosi M
Semin Respir Crit Care Med; 2012 Oct; 33(5):440-9. PubMed ID: 23001799
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic interstitial pneumonia: a clinicopathological perspective.
Thannickal VJ
Semin Respir Crit Care Med; 2006 Dec; 27(6):569-73. PubMed ID: 17195133
[TBL] [Abstract][Full Text] [Related]
6. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
Franzolini N; Quartuccio L; De Marchi G; De Vita S
Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
[TBL] [Abstract][Full Text] [Related]
8. Advances in immunosuppressive therapy.
Marder W; McCune WJ
Semin Respir Crit Care Med; 2007 Aug; 28(4):398-417. PubMed ID: 17764058
[TBL] [Abstract][Full Text] [Related]
9. [Treatment in diffuse interstitial lung diseases].
Kayacan O
Tuberk Toraks; 2005; 53(2):190-9. PubMed ID: 16100659
[TBL] [Abstract][Full Text] [Related]
10. Nonspecific interstitial pneumonia.
Flaherty KR; Martinez FJ
Semin Respir Crit Care Med; 2006 Dec; 27(6):652-8. PubMed ID: 17195141
[TBL] [Abstract][Full Text] [Related]
11. The evolving pharmacotherapy of pulmonary fibrosis.
Lota HK; Wells AU
Expert Opin Pharmacother; 2013 Jan; 14(1):79-89. PubMed ID: 23265249
[TBL] [Abstract][Full Text] [Related]
12. Treatment of interstitial lung diseases associated with connective tissue diseases.
Kobayashi A; Okamoto H
Expert Rev Clin Pharmacol; 2012 Mar; 5(2):219-27. PubMed ID: 22390563
[TBL] [Abstract][Full Text] [Related]
13. [Immunosuppressive therapy in interstitial lung diseases and immunologically-induced pneumonitis].
Müller-Quernheim J; Dalhoff K; Schnabel A
Internist (Berl); 1997 Jun; 38(6):553-61. PubMed ID: 9265000
[No Abstract] [Full Text] [Related]
14. Interstitial pneumonitis associated with sirolimus in liver transplantation: a case report.
Pérez MJ; Martín RO; García DM; Rey JM; de la Cruz Lombardo J; Rodrigo López JM
Transplant Proc; 2007 Dec; 39(10):3498-9. PubMed ID: 18089419
[TBL] [Abstract][Full Text] [Related]
15. Relevance of pharmacogenetic aspects of mercaptopurine metabolism in the treatment of interstitial lung disease.
Bakker JA; Drent M; Bierau J
Curr Opin Pulm Med; 2007 Sep; 13(5):458-63. PubMed ID: 17940494
[TBL] [Abstract][Full Text] [Related]
16. [Interstitial pneumonia associated with mixed connective tissue disease--marked improvement with azathioprine].
Suzuki M; Shimizu K; Sakamoto K; Iwase A; Aoki S; Matsuoka R; Nagayama T; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):101-5. PubMed ID: 8717301
[TBL] [Abstract][Full Text] [Related]
17. Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role?
Luppi F; Cerri S; Richeldi L
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S74-84. PubMed ID: 16457019
[TBL] [Abstract][Full Text] [Related]
18. Tobacco smoke-related diffuse lung diseases.
Vassallo R; Ryu JH
Semin Respir Crit Care Med; 2008 Dec; 29(6):643-50. PubMed ID: 19221962
[TBL] [Abstract][Full Text] [Related]
19. Interstitial lung diseases: an observational study in patients admitted in "Marius Nasta" Institute of Pulmonology Bucharest, Romania, in 2011.
Strâmbu I; Belaconi I; Stoicescu I; Ioniţă D; Cojocaru F; Niţă C; Dospinoiu D; Bumbăcea R
Pneumologia; 2013; 62(4):206-11. PubMed ID: 24734353
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of fibrosing diffuse parenchymal lung disease.
Morgenthau AS; Padilla ML
Mt Sinai J Med; 2009 Feb; 76(1):2-23. PubMed ID: 19170214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
